Cumming Vanessa, Ali Susanna, Forrester Terrence, Roye-Green Karen, Reid Marvin
Sickle Cell Unit, Tropical Medicine Research Institute, University of the West Indies, Mona Campus, Kingston 7, Jamaica.
BMC Infect Dis. 2006 Mar 15;6:46. doi: 10.1186/1471-2334-6-46.
It is known that there is significant morbidity associated with urinary tract infection and with renal dysfunction in sickle cell disease (SCD). However, it is not known if there are potential adverse outcomes associated with asymptomatic bacteriuria (ASB) infections in sickle cell disease if left untreated. This study was undertaken to determine the prevalence of ASB, in a cohort of patients with SCD.
This is a cross-sectional study of patients in the Jamaican Sickle Cell Cohort. Aseptically collected mid-stream urine (MSU) samples were obtained from 266 patients for urinalysis, culture and sensitivity analysis. Proteinuria was measured by urine dipsticks. Individuals with abnormal urine culture results had repeat urine culture. Serum creatinine was measured and steady state haematology and uric acid concentrations were obtained from clinical records. This was completed at a primary care health clinic dedicated to sickle cell diseases in Kingston, Jamaica. There were 133 males and 133 females in the sample studied. The mean age (mean +/- sd) of participants was 26.6 +/- 2.5 years. The main outcome measures were the culture of > or = 10(5) colony forming units of a urinary tract pathogen per milliliter of urine from a MSU specimen on a single occasion (probable ASB) or on consecutive occasions (confirmed ASB).
Of the 266 urines collected, 234 were sterile and 29 had significant bacteriuria yielding a prevalence of probable ASB of 10.9% (29/266). Fourteen patients had confirmed ASB (prevalence 5.3%) of which 13 had pyuria. Controlling for genotype, females were 14.7 times more likely to have confirmed ASB compared to males (95% CI 1.8 to 121.0). The number of recorded visits for symptomatic UTI was increased by a factor of 2.5 (95% CI 1.4 to 4.5, p < 0.005) but serum creatinine, uric acid and haematology values were not different in patients with confirmed ASB compared with those with sterile urine. There was no association with history of gram negative sepsis.
ASB is a significant problem in individuals with SCD and may be the source of pathogens in UTI. However, further research is needed to determine the clinical significance of ASB in SCD.
已知镰状细胞病(SCD)患者的尿路感染和肾功能障碍会导致严重发病。然而,目前尚不清楚镰状细胞病患者的无症状菌尿(ASB)感染若不治疗是否会产生潜在不良后果。本研究旨在确定一组镰状细胞病患者中无症状菌尿的患病率。
这是一项对牙买加镰状细胞队列患者的横断面研究。无菌采集266例患者的中段尿(MSU)样本,进行尿液分析、培养及药敏分析。用尿试纸检测蛋白尿。尿培养结果异常的个体进行重复尿培养。检测血清肌酐,并从临床记录中获取稳态血液学指标和尿酸浓度。该研究在牙买加金斯敦一家专门诊治镰状细胞病的初级保健健康诊所完成。研究样本中有133名男性和133名女性。参与者的平均年龄(均值±标准差)为26.6±2.5岁。主要观察指标为单次从MSU标本中培养出每毫升尿液中尿路病原体菌落形成单位≥10⁵(可能的无症状菌尿)或连续培养出(确诊的无症状菌尿)。
在采集的266份尿液中,234份无菌,29份有显著菌尿,可能的无症状菌尿患病率为10.9%(29/266)。14例患者确诊为无症状菌尿(患病率5.3%),其中13例有脓尿。在控制基因型后,女性确诊无症状菌尿的可能性是男性的14.7倍(95%可信区间1.8至121.0)。有症状性尿路感染的记录就诊次数增加了2.5倍(95%可信区间1.4至4.5,p<0.005),但确诊无症状菌尿的患者与无菌尿患者的血清肌酐、尿酸和血液学指标并无差异。与革兰阴性菌败血症病史无关。
无症状菌尿在镰状细胞病患者中是一个重要问题,可能是尿路感染的病原体来源。然而,需要进一步研究以确定无症状菌尿在镰状细胞病中的临床意义。